Literature DB >> 21571559

A girl with spastic tetraparesis associated with biotinidase deficiency.

Mustafa Komur1, Cetin Okuyaz, Fatih Ezgu, Aytug Atici.   

Abstract

Biotinidase deficiency is a disorder of biotin metabolism that manifests with cutaneous, ophthalmological and neurologyical symptoms in childhood. Spinal cord involvement has rarely been reported and all of the reported cases are spastic paraparesis. A 3 year-old girl with biotinidase deficiency was admitted to our clinic with hyperventilation, hair loss and spastic tetraparesis. To our knowledge, our case is the first reported tetraparesis associated with biotinidase deficiency. She was treated with oral biotin and benefited significantly from this therapy.
Copyright © 2011 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21571559     DOI: 10.1016/j.ejpn.2011.04.012

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

Review 1.  A Review of the Use of Biotin for Hair Loss.

Authors:  Deepa P Patel; Shane M Swink; Leslie Castelo-Soccio
Journal:  Skin Appendage Disord       Date:  2017-04-27

Review 2.  Inherited metabolic diseases mimicking hereditary spastic paraplegia (HSP): a chance for treatment.

Authors:  Hélio A G Teive; Carlos Henrique F Camargo; Eduardo R Pereira; Léo Coutinho; Renato P Munhoz
Journal:  Neurogenetics       Date:  2022-04-09       Impact factor: 3.017

3.  Management of anesthesia in biotinidase deficiency.

Authors:  Ugur Goktas; Muhammed Bilal Cegin; Ismail Kati; Onur Palabiyik
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-01

4.  Severe Distal Motor Involvement in a Non-compliant Adult With Biotinidase Deficiency: The Necessity of Life-Long Biotin Therapy.

Authors:  Géraldine Van Winckel; Diana Ballhausen; Barry Wolf; Melinda Procter; Rong Mao; Patricie Burda; Davide Strambo; Thierry Kuntzer; Christel Tran
Journal:  Front Neurol       Date:  2020-10-26       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.